FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2465673967> ?p ?o ?g. }

• W2465673967 endingPage "41" @default.
• W2465673967 startingPage "1" @default.
• W2465673967 abstract "The mutagenic and carcinogenic effects of 1,3-butadiene (BD*) are related to its bioactivation to several DNA-reactive metabolites, including 1,2-epoxy-3-butene (BDO), 1,2,3,4-diepoxybutane (BDO2), and 1,2-dihydroxy-3,4-epoxybutane (BDO-diol). Accumulated evidence indicates that stereochemical configurations of BD metabolites may play a role in the mutagenic and carcinogenic action of BD. The objective of this study was to evaluate the cytotoxicity and mutagenicity of each stereoisomer of major BD metabolites in human cells. For this purpose, nine stereochemical forms of BDO, BDO2, and BDO-diol were synthesized. TK6 cells, a human lymphoblastoid cell line, were exposed to each stereoisomer. Cytotoxicity was measured by comparing cloning efficiencies (CEs) in chemical-exposed cells versus those in control cells. Based on the results of cytotoxicity tests, TK6 cells were exposed to 0; 2, 4, or 6 pM of each form of BDO2, or to 0, 200, 400, or 600 pMof each form of BDO for 24 hours to determine the mutagenic efficiencies. The exposure concentrations for BDO-diol ranged from 5 to 1000 pM. The mutagenicity was measured by determining, in a lymphocyte cloning assay, the mutant frequencies (Mfs) in the hypoxanthine-guanine phosphoribosyltransferase (HPRT) and thymidine kinase (TK) genes. HPRT mutants collected from cells exposed to the three forms of BDO2 were analyzed by polymerase chain reaction (PCR) to characterize large genetic alterations. All three stereoisomers of BDO2 [(2R,3R)-BDO2, (2S,3S)-BDO2, and meso-BDO2] caused increased HPRT and TK Mfs compared with the concurrent control samples, with P values ranged from 0.05 to 0.001. There were no significant differences in cytotoxicity or mutagenicity among the three isomers of BDO2. Molecular analysis ofHPRTmutants revealed similar distributions of deletion mutations caused by the three isomers of BDO2. There were also no statistical differences in mutagenic efficiencies between the two isomers of BDO [(2R)-BDO and (2S)-BDO] in TK6 cells. These results were consistent with the in vivo finding that there was little difference in the mutagenic efficiencies of (+)-BDO2 versus meso-BDO2 in rodents. Thus, in terms of mutagenic potency, there was no evidence that stereochemical configurations of BDO and BDO2 play a significant role in the mutagenicity and carcinogenicity of BD. The most significant results of this study were the marked differences in cytotoxicity and mutagenicity among the four stereoisomers of BDO-diol [(2R,3R)-BDO-diol, (2R,3S)-BDO-diol, (2S,3R)-BDO-diol, and (2S,3S)-BDO-diol]. (2R,3S)-BDO-diol was at least 30-fold more cytotoxic and mutagenic than the other three forms of BDO-diol. This was consistent with the finding that 75% of the adduct N7-(2,3,4-trihydroxybutyl)guanine (THB-Gua) originated from (2R,3S)-BDO-diol in the lungs of mice exposed to BD. The mutagenic potency of (2R,3S)-BDO-diol was much closer to that of BDO2 than previously demonstrated in experiments in which stereochemistry was not considered. The current study demonstrated that the mutagenic potency of (2R,3S)-BDO-diol was only 5-to-l0-fold less than the average equimolar effect of BDO2 stereoisomers in the HPRT and TK genes, and was 10-to-20-fold greater than the average equimolar effect of BDO stereoisomers in the HPRT and TKgenes. Previous DNA and hemoglobin adduct data demonstrated that BDO-diol is the dominant BD metabolite available to react with macromolecules in vivo after BD exposure (Pérez et al. 1997; Swenberg et al. 2001). Thus, the differences in BD carcinogenesis among rodent species may be significantly accounted for by the stereochemistry-dependent distributions of BDO-diol metabolites and BDO-diol-DNA adducts, and by the mutagenic efficiencies of BDO-diol in mice and rats." @default.
• W2465673967 created "2016-07-22" @default.
• W2465673967 creator A5025846641 @default.
• W2465673967 creator A5033191863 @default.
• W2465673967 creator A5039613182 @default.
• W2465673967 creator A5061830702 @default.
• W2465673967 creator A5079273909 @default.
• W2465673967 creator A5090756006 @default.
• W2465673967 date "2010-06-01" @default.
• W2465673967 modified "2023-09-27" @default.
• W2465673967 title "Mutagenicity of stereochemical configurations of 1,3-butadiene epoxy metabolites in human cells." @default.
• W2465673967 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20853577" @default.
• W2465673967 hasPublicationYear "2010" @default.
• W2465673967 type Work @default.
• W2465673967 sameAs 2465673967 @default.
• W2465673967 citedByCount "2" @default.
• W2465673967 countsByYear W24656739672022 @default.
• W2465673967 crossrefType "journal-article" @default.
• W2465673967 hasAuthorship W2465673967A5025846641 @default.
• W2465673967 hasAuthorship W2465673967A5033191863 @default.
• W2465673967 hasAuthorship W2465673967A5039613182 @default.
• W2465673967 hasAuthorship W2465673967A5061830702 @default.
• W2465673967 hasAuthorship W2465673967A5079273909 @default.
• W2465673967 hasAuthorship W2465673967A5090756006 @default.
• W2465673967 hasConcept C104317684 @default.
• W2465673967 hasConcept C109316439 @default.
• W2465673967 hasConcept C113842279 @default.
• W2465673967 hasConcept C114246631 @default.
• W2465673967 hasConcept C143065580 @default.
• W2465673967 hasConcept C143425029 @default.
• W2465673967 hasConcept C153911025 @default.
• W2465673967 hasConcept C161790260 @default.
• W2465673967 hasConcept C181199279 @default.
• W2465673967 hasConcept C185592680 @default.
• W2465673967 hasConcept C202751555 @default.
• W2465673967 hasConcept C2522874641 @default.
• W2465673967 hasConcept C2776147627 @default.
• W2465673967 hasConcept C2777761686 @default.
• W2465673967 hasConcept C2778301229 @default.
• W2465673967 hasConcept C2780887139 @default.
• W2465673967 hasConcept C2781116151 @default.
• W2465673967 hasConcept C2781196997 @default.
• W2465673967 hasConcept C512185932 @default.
• W2465673967 hasConcept C54355233 @default.
• W2465673967 hasConcept C552990157 @default.
• W2465673967 hasConcept C55493867 @default.
• W2465673967 hasConcept C78179603 @default.
• W2465673967 hasConcept C81885089 @default.
• W2465673967 hasConcept C86803240 @default.
• W2465673967 hasConceptScore W2465673967C104317684 @default.
• W2465673967 hasConceptScore W2465673967C109316439 @default.
• W2465673967 hasConceptScore W2465673967C113842279 @default.
• W2465673967 hasConceptScore W2465673967C114246631 @default.
• W2465673967 hasConceptScore W2465673967C143065580 @default.
• W2465673967 hasConceptScore W2465673967C143425029 @default.
• W2465673967 hasConceptScore W2465673967C153911025 @default.
• W2465673967 hasConceptScore W2465673967C161790260 @default.
• W2465673967 hasConceptScore W2465673967C181199279 @default.
• W2465673967 hasConceptScore W2465673967C185592680 @default.
• W2465673967 hasConceptScore W2465673967C202751555 @default.
• W2465673967 hasConceptScore W2465673967C2522874641 @default.
• W2465673967 hasConceptScore W2465673967C2776147627 @default.
• W2465673967 hasConceptScore W2465673967C2777761686 @default.
• W2465673967 hasConceptScore W2465673967C2778301229 @default.
• W2465673967 hasConceptScore W2465673967C2780887139 @default.
• W2465673967 hasConceptScore W2465673967C2781116151 @default.
• W2465673967 hasConceptScore W2465673967C2781196997 @default.
• W2465673967 hasConceptScore W2465673967C512185932 @default.
• W2465673967 hasConceptScore W2465673967C54355233 @default.
• W2465673967 hasConceptScore W2465673967C552990157 @default.
• W2465673967 hasConceptScore W2465673967C55493867 @default.
• W2465673967 hasConceptScore W2465673967C78179603 @default.
• W2465673967 hasConceptScore W2465673967C81885089 @default.
• W2465673967 hasConceptScore W2465673967C86803240 @default.
• W2465673967 hasIssue "150" @default.
• W2465673967 hasLocation W24656739671 @default.
• W2465673967 hasOpenAccess W2465673967 @default.
• W2465673967 hasPrimaryLocation W24656739671 @default.
• W2465673967 hasRelatedWork W1526327087 @default.
• W2465673967 hasRelatedWork W1577812194 @default.
• W2465673967 hasRelatedWork W1972727374 @default.
• W2465673967 hasRelatedWork W1977552183 @default.
• W2465673967 hasRelatedWork W1981299725 @default.
• W2465673967 hasRelatedWork W1985651655 @default.
• W2465673967 hasRelatedWork W1997345646 @default.
• W2465673967 hasRelatedWork W2001611849 @default.
• W2465673967 hasRelatedWork W2004933867 @default.
• W2465673967 hasRelatedWork W2006901186 @default.
• W2465673967 hasRelatedWork W2055908271 @default.
• W2465673967 hasRelatedWork W2060389159 @default.
• W2465673967 hasRelatedWork W2074650605 @default.
• W2465673967 hasRelatedWork W2089706668 @default.
• W2465673967 hasRelatedWork W2104023998 @default.
• W2465673967 hasRelatedWork W2112468367 @default.
• W2465673967 hasRelatedWork W2170928896 @default.
• W2465673967 hasRelatedWork W2184728709 @default.
• W2465673967 hasRelatedWork W61904189 @default.
• W2465673967 hasRelatedWork W2162370967 @default.

• next